United States · Platforms & data · Investing.com

ArriVent reports phase 1 data for cancer drug ARR-217

Published by Investing.com · United States 3 h ago

Read the full article on Investing.com Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investing.com)

Also worth reading

Aclara Resources Targets Rare-Earth Supply Chain From South America to Louisiana

The Motley Fool

Dow: 3 Key Takeaways for Long-Term Investors

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

‘She’s living the dream’: My stepmother said I can buy my childhood home for $850,000. Is she taking advantage of me?

France protests draw 400,000 as unrest threatens Macron’s final months

Why Hershey’s Sneaky Volume Problem Could Spoil Its Q3 on Oct. 29?